COVID Vaccines

Indian Government has asked its states and Union Territories to review the coverage of second dose, amongst adolescents daily, stating that timely completion of the Covid vaccination schedule is important to ensure full protection of vaccines to the recipients, . In a letter to the states and UTs, Union Health Secretary Rajesh Bhushan said a well structured communication strategy, focused at adolescent population and their...

Bharat Biotech Intranasal Vaccine (BBV154) for COVID-19 today received approval from the Drug Controller General of India to conduct Phase-III clinical trials. The trials will be conducted at nine locations in the country. The trials will evaluate BBV154 nasal vaccine for both the 2 dose primary schedule and booster dose schedule. An intranasal vaccine as a booster will be easier to administer in mass vaccination drives. Bharat...

Bharat Biotech's COVAXIN will now be available in the regular market as the Drug Controller General of India today gave conditional market approval to the indigenous made Covid vaccine on Thursday. The subject expert committee of the Central Drug Standard Control Organisation has earlier recommended granting regular market approval to the two Covid-19 vaccines for the adult population, subject to certain conditions. Market approval...

As Omicron is disturbing life across globe Pfizer and BioNTech made it public on Tuesday that they have started a study comparing their Omicron-based Covid-19 vaccine against the original vaccine. Initial data from the research, which will enrol 1,420 volunteers, is expected in the first half of 2022, according to Pfizer. The company says, if regulators decide to wait for the results of such a study,...

COVID Vaccine for 15-18 Years has got tremendous momentum in India since its launch. India's Health Minister Mansukh Mandaviya shared an update on Tuesday evening to announce that more than fifty per cent of India's population in the 15 to 18 years age group have received their first dose of the Covid-19 vaccine. Health Minister wrote that it was a big day in India's fight...

COVID Vaccine Precautionary Dose campaign which began on January 10, crossed a figure of 50 lakh jabs, as the healthcare staff, frontline workers, and people aged 60 and up have received the COVID-19 vaccination, according to Union Health Minister Mansukh Mandaviya. According to provisional statistics, the cumulative COVID-19 vaccine doses administered in the country has crossed 158.04 crore as of 7 a.m., with approximately 80 lakh...

COVAXIN Booster Shown to Neutralize Both Omicron and Delta Variants of SARS-CoV-2. Bharat Biotech announced today the results from a study conducted at Emory University demonstrating that sera from subjects who received a booster dose of COVAXIN® (BBV152)six months after getting a primary two-dose series of COVAXIN® (BBV152), neutralized the SARS-CoV-2 Omicronand Delta variants. Earlier studies demonstrated the neutralizing potential of COVAXIN® (BBV152) against...

The Union Health Ministry on Friday termed as "highly ill-informed" and "misleading" media reports suggesting that approval for the Covaxin vaccine in the 15-18 age group has been given despite the WHO not having accorded Emergency Use Listing (EUL) to its use in this age bracket. The guidelines issued by the Union Ministry of Health at no place mention about EUL by WHO, it said. Health...

COVAXIN Shelf Life, what is it, need to be understood clearly, which all parents and their children ought to know. Before this, it is important to also note the vaccination for 15-18 years children got off to a very healthy start, with parents reaching sites to get their children vaccinated in large numbers. On day one over 41 lakh teenagers having already received their...

India has kicked off a massive campaign to begin COVAXIN for Children today. As the vaccination for children of 15-18 years started with great response from parents and children, the makers of COVAXIN has chalked out plans to consolidate, expand vaccine supplies, with the goal of reaching 100 crore doses of Covaxin by 2022. For this segment, Covaxin is the only vaccine approved in...